Call Number (LC) Title Results
HD9665.5 .O94 2012 The Oxford handbook of the economics of the biopharmaceutical industry /
The Oxford handbook of the economics of the biopharmaceutical industry 		2
HD9665.5 .P35 2009 Pharmaceutical product branding strategies : simulating patient flow and portfolio dynamics / 1
HD9665.5 .P35 2009eb Pharmaceutical product branding strategies simulating patient flow and portfolio dynamics / 1
HD9665.5 .P365 2007 Innovation and industrial leadership : lessons from pharmaceuticals / 1
HD9665.5 .P37 2003eb Information technology & FDA compliance in the pharmaceutical industry /
The 2003-2008 world outlook for drugs / 		2
HD9665.5 .P43 2013i Pharmaceutical innovation, competition and patent law a trilateral perspective / 1
HD9665.5 .P437 2016eb Pharmaceutical Market Access in Emerging Markets. 1
HD9665.5 .P437 2018eb Pharmaceutical Market Access in Developed Markets. 1
HD9665.5 .P494 2010eb Pharmaceutical and biomedical project management in a changing global environment
Pharmaceutical and biomedical project management in a changing global environment / 		2
HD9665.5 .P524 2011 Pharmaceutical marketing in the 21st century / 1
HD9665.5 .P67 2010 Portfolio, program, and project management in the pharmaceutical and biotechnology industries /
Portfolio, program, and project management in the pharmaceutical and biotechnology industries 		2
HD9665.5 .P72 1983 International pharmaceutical marketing / 1
HD9665.5 .P73 1992 The Prescription drug market : international perspectives and challenges for the future / 1
HD9665.5 .P73 2002  
HD9665.5 .R44 2006eb Risk-sharing in the pharmaceutical industry the case of out-licensing / 1
HD9665.5 .R44 2011 Supply chain management in the drug industry : delivering patient value for pharmaceuticals and biologics / 2
HD9665.5 .R57 2013eb Risk management applications in pharmaceutical and biopharmaceutical manufacturing
Risk management applications in pharmaceutical and biopharmaceutical manufacturing / 		3
HD9665.5 .S45 2015 Selling sickness / 2
HD9665.5 .S56 Thalidomide and the power of the drug companies / 1
HD9665.5 .S57 2018eb Ghost-managed medicine Big Pharma's invisible hands / 1